Search Results - Peter Rossing

Cardiovascular and non‐renal complications of chronic kidney disease: Managing risk by Peter Rossing, Tine Willum Hansen, Thomas Kümler

Get full text

The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease by Johannes David Smeijer, Maria F. Gomez, Peter Rossing, Hiddo J. L. Heerspink

Get full text

Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐l... by Peter Rossing, Malik Benamar, Alice Y. Y. Cheng, Bharath Kumar, Christian Laugesen, Harpreet S. Bajaj

Get full text

Association of carpal tunnel syndrome with incident diabetes by Jeppe Ravn Jacobsen, Lucas Malta Westergaard, Emil L. Fosbøl, Søren L. Kristensen, Lars Køber, Frederik Persson, Peter Rossing, Rasmus Rørth

Get full text

Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real‐world evidence from a 22‐year follow‐up study by Abhilasha Akerkar, Pernille F. Rønn, Vanja Kosjerina, Christian Stevns Hansen, Adam Hulman, Frederik Persson, Anne Rasmussen, Peter Rossing, Tarunveer S. Ahluwalia

Get full text

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease by Victor Wasehuus, J. David Smeijer, Phil Ambery, Peter J. Greasley, Emma Wijkmark, David C. Wheeler, Peter Rossing, Hiddo J. L. Heerspink

Get full text

Aldosterone synthase inhibitor ( BI 690517) therapy for people with diabetes and albuminuric chronic kidney disease: A multicentre, randomized, double‐blind, placebo‐controlled, Ph... by Stefan R. Bornstein, Dick de Zeeuw, Hiddo J. L. Heerspink, Friedrich Schulze, Lisa Cronin, Arne Wenz, Katherine R. Tuttle, Samy Hadjadj, Peter Rossing

Get full text

Effect of Dapagliflozin on Measured vs. Panel‐Estimated Glomerular Filtration Rate by Esben Iversen, Line Juel Nielsen, Viktor Rotbain Curovic, Anne Byriel Walls, Mie Klessen Eickhoff, Marie Frimodt‐Møller, Frederik Persson, Peter Rossing, Morten Baltzer Houlind

Get full text

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes by Jonas A. Andersen, Tommi Suvitaival, Kajetan Trošt, María J. Romero‐Lado, Simone Theilade, Ismo Matias Mattila, Marie Frimodt‐Møller, Anne Rasmussen, Peter Rossing, Cristina Legido‐Quigley, Tarunveer Singh Ahluwalia

Get full text

Effect of spironolactone wash‐out on albuminuria after long‐term treatment in individuals with type 2 diabetes and high risk of kidney disease—An observational follow‐up of the PRI... by Victor Wasehuus, Viktor Rotbain Curovic, Nete Tofte, Morten Lindhardt, Gemma Currie, Christian Delles, Marie Frimodt‐Møller, Harald Mischak, Heiko von der Leyen, Tine Willum Hansen, Thomas Kümler, Frederik Persson, Peter Rossing

Get full text

Performance of new and panel CKD‐EPI equations in European adults with type 2 diabetes by Esben Iversen, Katrine McLain Christensen, Anne Byriel Walls, Mie Klessen Eickhoff, Bernt Johan von Scholten, Marie Frimodt‐Møller, Tine Willum Hansen, Frederik Persson, Peter Rossing, Viktor Rotbain Curovic, Morten Baltzer Houlind

Get full text

Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis by João Sérgio Neves, Ana Rita Leite, Francisco Vasques‐Nóvoa, Bertram Pitt, Gerasimos Filippatos, Luis M. Ruilope, Peter Rossing, Stefan D. Anker, Gianluigi Savarese, Charlie A. B. Scott, Andrea Lage, Meike D. Brinker, João Pedro Ferreira

Get full text

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses by David Z. I. Cherney, Peter Rossing, Maria Eugenia Canziani, Maria Luiza Caramori, Ricardo Correa‐Rotter, Lisa Cronin, Christian Hugo, Bo Ji, Juliane Meyerhoff, Masaomi Nangaku, Arnold Silva, Dorothea Urbach, Shimoli V. Shah, Dick de Zeeuw, Katherine R. Tuttle

Get full text

iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 by Stefan D. Anker, Linong Ji, Tammy Kindel, Andrew J. S. Coats, Dike Ojji, Adriana Puente Barragán, Peter Rossing, Shelley Zieroth, Shaaf Ahmad, Shariq Usman, Geeta Appannah, Alison L. Bailey, Ahmed Bennis, Andrea Brandao, Javed Butler, Melanie J. Davies, Lubomira Fabryova, Yuan‐Lin Guo, Hidetaka Itoh, Uday M. Jadhav, Carel W. Le Roux, Fausto J. Pinto, Julio Rosenstock, Banshi Saboo, Hani Sabbour, Mangesh Tiwaskar, Karol E. Watson, Kwang Wei Tham, Fernando Stuardo Wyss, Walter P. Abhayaratna, William T. Abraham, Wael Al Mahmeed, Alessia Argirò, John J. Atherton, Danielle Belardo, Raquel Campuzano, Nandini Chatterjee, Marc‐André Cornier, Sarah Davies, Clemencia de Rueda Panadero, Anastase Dzudie, Ty J. Gluckman, Muhammad Shahzeb Khan, Kamlesh Khunti, Yuri Lopatin, Zhiyi Ma, Okechukwu S. Ogah, Abraham Oomman, Emilio S. Peralta Lopez, Ping Li, Paul Poirier, Julie Redfern, Giuseppe M. C. Rosano, Donna Ryan, Amit Saraf, Sameh Shaheen, Subodh Verma, Stephan von Haehling, Martha Gulati, Naveed Sattar, Jose Luis Zamorano

Get full text